Cadrenal Therapeutics, Inc. (CVKD)
(Delayed Data from NSDQ)
$0.47 USD
0.00 (0.86%)
Updated Jul 11, 2024 04:00 PM ET
4-Sell of 5 4
F Value D Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Cadrenal Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -8.36 | -6.71 | NA | NA | NA |
Depreciation/Amortization & Depletion | 0.02 | 0.14 | NA | NA | NA |
Net Change from Assets/Liabilities | 0.14 | 0.61 | NA | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | NA | NA | NA |
Other Operating Activities | 4.67 | 4.83 | NA | NA | NA |
Net Cash From Operating Activities | -3.53 | -1.20 | NA | NA | NA |
Property & Equipment | 0.00 | 0.00 | NA | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | NA | NA | NA |
Investments | 0.00 | 0.00 | NA | NA | NA |
Other Investing Activities | 0.00 | 0.00 | NA | NA | NA |
Net Cash from Investing Activities | 0.00 | 0.00 | NA | NA | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 12.15 | 0.01 | NA | NA | NA |
Issuance (Repayment) of Debt | 0.00 | 1.23 | NA | NA | NA |
Increase (Decrease) Short-Term Debt | -0.25 | 0.22 | NA | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | NA | NA | NA |
Other Financing Activities | 0.00 | 0.00 | NA | NA | NA |
Net Cash from Financing Activities | 11.90 | 1.24 | NA | NA | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | NA | NA | NA |
Net Change In Cash & Equivalents | 8.37 | 0.03 | NA | NA | NA |
Cash at Beginning of Period | 0.03 | 0.00 | NA | NA | NA |
Cash at End of Period | 8.40 | 0.03 | NA | NA | NA |
Diluted Net EPS | -0.62 | -0.85 | NA | NA | NA |
Fiscal Year End for Cadrenal Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -1.66 | -8.36 | -7.21 | -6.18 |
Depreciation/Amortization & Depletion | NA | 0.00 | 0.02 | 0.01 | 0.01 |
Net Change from Assets/Liabilities | NA | -0.34 | 0.14 | -0.20 | -0.46 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 0.16 | 4.67 | 4.56 | 4.41 |
Net Cash From Operating Activities | NA | -1.84 | -3.53 | -2.84 | -2.21 |
Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 12.15 | 12.17 | 5.66 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | -0.25 | -0.25 | -0.25 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 0.00 | 11.90 | 11.92 | 5.41 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -1.84 | 8.37 | 9.08 | 3.20 |
Cash at Beginning of Period | NA | 8.40 | 0.03 | 0.03 | 0.03 |
Cash at End of Period | NA | 6.57 | 8.40 | 9.11 | 3.23 |
Diluted Net EPS | NA | -0.10 | 0.02 | -0.07 | -0.09 |